ArticleBMJ nutrition, prevention & health2026
Meta-analysis of lactase phenotypes on obesity, metabolic syndrome and milk consumption.
Article in BMJ nutrition, prevention & health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The variability in lactose digestion ability is categorised into lactase persistence and lactase non-persistence phenotypes, primarily determined by the 13 910 C>T single nucleotide polymorphism (rs4988235). The relationship between the lactase gene, obesity and milk consumption has been studied, but the result remains discrepant. We aimed to investigate the association between lactase phonotypes/genotypes and obesity while also exploring potential connections with metabolic syndrome and milk consumption. Objective: To investigate the association between lactase phenotypes/genotypes and 1) body mass index, 2) obesity/overweight status, 3) metabolic syndrome and 4) milk consumption. Methods: A systematic literature search of Medline (via PubMed search engine) and Scopus databases was conducted up to August 2023. Data extraction was performed independently by three investigators. Meta-analysis utilised fixed and random effects, with heterogeneity assessed using Higgin's I² statistic. Publication bias was examined using funnel plots. Results: Twenty-six studies were included (5 in children, 21 in adults). In children, body mass index did not significantly differ based on the lactase phenotypes (mean difference 0.17 kg/m², 95% CI -0.26 to 0.60; p=0.44 (three studies)). However, among adults, lactase persistence individuals had a higher body mass index (mean difference 0.22 kg/m², 95% CI 0.15 to 0.30; p<0.01 (19 studies)) and an increased risk of obesity/overweight by 27% (OR 1.27, 95% CI 1.07 to 1.52; p=0.01 (four studies)) as compared with the lactase non-persistence. Even though it was not associated with metabolic syndrome (OR 0.98, 95% CI 0.61 to 1.57; p=0.93 [three studies]), lactase persistence was associated with higher milk consumption (mean difference of 41 g/day, 95% CI 26 to 56, p<0.01 [six studies]). Conclusions: While data on lactase phenotype and obesity in children are limited, adults with lactase persistence have higher body mass index and risk of obesity/overweight and greater milk consumption than lactase non-persistence. More research is needed to define the interplay between lactase genotypes/phenotypes, obesity and milk consumption. PROSPERO registration number: CRD42023400753.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.